BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Smith MG, Hold GL, Tahara E, El-Omar EM. Cellular and molecular aspects of gastric cancer. World J Gastroenterol 2006; 12(19): 2979-2990 [PMID: 16718776 DOI: 10.3748/wjg.v12.i19.2979] [Cited by in CrossRef: 145] [Cited by in F6Publishing: 145] [Article Influence: 9.1] [Reference Citation Analysis]
Number Citing Articles
1 Dalal RS, Moss SF. At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer. J Leukoc Biol 2014;96:213-24. [PMID: 24823809 DOI: 10.1189/jlb.4BT0214-100R] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Wang AM, Huang TT, Hsu KW, Huang KH, Fang WL, Yang MH, Lo SS, Chi CW, Lin JJ, Yeh TS. Yin Yang 1 is a target of microRNA-34 family and contributes to gastric carcinogenesis. Oncotarget 2014;5:5002-16. [PMID: 24970812 DOI: 10.18632/oncotarget.2073] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 7.3] [Reference Citation Analysis]
3 Zeng J, Ge Z, Wang L, Li Q, Wang N, Björkholm M, Jia J, Xu D. The Histone Demethylase RBP2 Is Overexpressed in Gastric Cancer and Its Inhibition Triggers Senescence of Cancer Cells. Gastroenterology 2010;138:981-92. [DOI: 10.1053/j.gastro.2009.10.004] [Cited by in Crossref: 110] [Cited by in F6Publishing: 99] [Article Influence: 9.2] [Reference Citation Analysis]
4 de Souza CR, Leal MF, Calcagno DQ, Costa Sozinho EK, Borges Bdo N, Montenegro RC, Dos Santos AK, Dos Santos SE, Ribeiro HF, Assumpção PP, de Arruda Cardoso Smith M, Burbano RR. MYC deregulation in gastric cancer and its clinicopathological implications. PLoS One 2013;8:e64420. [PMID: 23717612 DOI: 10.1371/journal.pone.0064420] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 6.1] [Reference Citation Analysis]
5 Tang X, Hu G, Xu C, Ouyang K, Fang W, Huang W, Zhang J, Li F, Wang K, Qin X, Li Y. HZ08 reverse the aneuploidy-induced cisplatin-resistance in Gastric cancer by modulating the p53 pathway. Eur J Pharmacol 2013;720:84-97. [PMID: 24183976 DOI: 10.1016/j.ejphar.2013.10.045] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
6 Calcagno DQ, Leal MF, Demachki S, Araújo MT, Freitas FW, Oliveira e Souza D, Assumpção PP, Ishak G, de Arruda Cardoso Smith M, Burbano RR. MYC in gastric carcinoma and intestinal metaplasia of young adults. Cancer Genet Cytogenet 2010;202:63-6. [PMID: 20804924 DOI: 10.1016/j.cancergencyto.2010.05.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
7 Lima VP, Lima MAP, André AR, Ferreira MVP, Barros MAP, Rabenhorst SHB. H pylori (CagA) and Epstein-Barr virus infection in gastric carcinomas: Correlation with p53 mutation and c-Myc, Bcl-2 and Bax expression. World J Gastroenterol 2008; 14(6): 884-891 [PMID: 18240345 DOI: 10.3748/wjg.14.884] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
8 Tseng YC, Tsai YH, Tseng MJ, Hsu KW, Yang MC, Huang KH, Li AF, Chi CW, Hsieh RH, Ku HH. Notch2-induced COX-2 expression enhancing gastric cancer progression. Mol Carcinog. 2012;51:939-951. [PMID: 21976141 DOI: 10.1002/mc.20865] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
9 Qin H, Cai A, Xi H, Yuan J, Chen L. ZnRF3 Induces Apoptosis of Gastric Cancer Cells by Antagonizing Wnt and Hedgehog Signaling. Cell Biochem Biophys 2015;73:361-7. [PMID: 27352324 DOI: 10.1007/s12013-015-0607-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
10 Han ME, Jeon TY, Hwang SH, Lee YS, Kim HJ, Shim HE, Yoon S, Baek SY, Kim BS, Kang CD. Cancer spheres from gastric cancer patients provide an ideal model system for cancer stem cell research. Cell Mol Life Sci. 2011;68:3589-3605. [PMID: 21448722 DOI: 10.1007/s00018-011-0672-z] [Cited by in Crossref: 91] [Cited by in F6Publishing: 83] [Article Influence: 8.3] [Reference Citation Analysis]
11 Wu HH, Lin WC, Tsai KW. Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers. Expert Rev Mol Med. 2014;16:e1. [PMID: 24456939 DOI: 10.1017/erm.2013.16] [Cited by in Crossref: 101] [Cited by in F6Publishing: 103] [Article Influence: 12.6] [Reference Citation Analysis]
12 Tahara E. Abnormal growth factor/cytokine network in gastric cancer. Cancer Microenviron 2008;1:85-91. [PMID: 19308687 DOI: 10.1007/s12307-008-0008-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
13 Baek S, Lee YS, Shim HE, Yoon S, Baek SY, Kim BS, Oh SO. Vitamin D3 regulates cell viability in gastric cancer and cholangiocarcinoma. Anat Cell Biol 2011;44:204-9. [PMID: 22025972 DOI: 10.5115/acb.2011.44.3.204] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
14 Lima VP, de Lima MA, Ferreira MV, Barros MA, Rabenhorst SH. The relationship between Helicobacter pylori genes cagE and virB11 and gastric cancer. Int J Infect Dis. 2010;14:e613-e617. [PMID: 20106696 DOI: 10.1016/j.ijid.2009.09.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
15 Sun K, Tang XH, Xie YK. Paclitaxel combined with harmine inhibits the migration and invasion of gastric cancer cells through downregulation of cyclooxygenase-2 expression. Oncol Lett 2015;10:1649-54. [PMID: 26622726 DOI: 10.3892/ol.2015.3425] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
16 da Costa Jde F, Leal MF, Silva TC, Andrade Junior EF, Rezende AP, Muniz JA, Lacreta Junior AC, Assumpção PP, Calcagno DQ, Demachki S, Rabenhorst SH, Smith Mde A, Burbano RR. Experimental gastric carcinogenesis in Cebus apella nonhuman primates. PLoS One 2011;6:e21988. [PMID: 21811552 DOI: 10.1371/journal.pone.0021988] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
17 Uddin S, Bhat AA, Krishnankutty R, Mir F, Kulinski M, Mohammad RM. Involvement of F-BOX proteins in progression and development of human malignancies. Seminars in Cancer Biology 2016;36:18-32. [DOI: 10.1016/j.semcancer.2015.09.008] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
18 Ahadi M, Moradi A, Musavinejad L, Movafagh A, Moradi A. The Expression of p53, CD44, Ki-67, and HER-2/neu Markers in Gastric Cancer and Its Association with Histopathological Indicators: A Retrospective Study. Asian Pac J Cancer Prev 2020;21:1607-14. [PMID: 32592354 DOI: 10.31557/APJCP.2020.21.6.1607] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Liu YY, Chen HY, Zhang ML, Tian D, Li S, Lee JY. Loss of fragile histidine triad and amplification of 1p36.22 and 11p15.5 in primary gastric adenocarcinomas. World J Gastroenterol 2012; 18(33): 4522-4532 [PMID: 22969225 DOI: 10.3748/wjg.v18.i33.4522] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
20 Alves MKS, Lima VP, André ÂR, Ferreira MVP, Barros MAP, Rabenhorst SHB. p27 KIP1 expression in gastric cancer: Differential pathways in the histological subtypes associated with Helicobacter pylori infection. Scandinavian Journal of Gastroenterology 2010;45:409-20. [DOI: 10.3109/00365520903521566] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
21 Tänzer M, Liebl M, Quante M. Molecular biomarkers in esophageal, gastric, and colorectal adenocarcinoma. Pharmacol Ther. 2013;140:133-147. [PMID: 23791941 DOI: 10.1016/j.pharmthera.2013.06.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
22 Darnet S, Moreira FC, Hamoy IG, Burbano R, Khayat A, Cruz A, Magalhães L, Silva A, Santos S, Demachki S, Assumpção M, Assumpção P, Ribeiro-dos-santos Â. High-Throughput Sequencing of miRNAs Reveals a Tissue Signature in Gastric Cancer and Suggests Novel Potential Biomarkers. Bioinform Biol Insights 2015;9s1:BBI.S23773. [DOI: 10.4137/bbi.s23773] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
23 Zhang T, Chen YN, Wang Z, Chen JQ, Huang S. Effect of PSCA gene polymorphisms on gastric cancer risk and survival prediction: A meta-analysis. Exp Ther Med. 2012;4:158-164. [PMID: 23060941 DOI: 10.3892/etm.2012.563] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
24 Khatoon J, Rai RP, Prasad KN. Role of Helicobacter pylori in gastric cancer: Updates. World J Gastrointest Oncol 2016; 8(2): 147-158 [PMID: 26909129 DOI: 10.4251/wjgo.v8.i2.147] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
25 Chung HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY, Carter C, Yu BP, Leeuwenburgh C. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev 2009;8:18-30. [PMID: 18692159 DOI: 10.1016/j.arr.2008.07.002] [Cited by in Crossref: 725] [Cited by in F6Publishing: 659] [Article Influence: 51.8] [Reference Citation Analysis]
26 Hold GL, El-Omar EM. Genetic aspects of inflammation and cancer. Biochem J. 2008;410:225-235. [PMID: 18254728 DOI: 10.1042/bj20071341] [Cited by in Crossref: 74] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
27 Shi M, Liu D, Duan H, Han C, Wei B, Qian L, Chen C, Guo L, Hu M, Yu M, Song L, Shen B, Guo N. Catecholamine up-regulates MMP-7 expression by activating AP-1 and STAT3 in gastric cancer. Mol Cancer. 2010;9:269. [PMID: 20939893 DOI: 10.1186/1476-4598-9-269] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 3.0] [Reference Citation Analysis]
28 Puneet, Kazmi HR, Kumari S, Tiwari S, Khanna A, Narayan G. Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers. Pathol Oncol Res. 2018;24:757-770. [PMID: 29552712 DOI: 10.1007/s12253-018-0410-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
29 Zeng J, Wang L, Li Q, Li W, Björkholm M, Jia J, Xu D. FoxM1 is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27kip 1. J Pathol 2009;218:419-27. [DOI: 10.1002/path.2530] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 5.5] [Reference Citation Analysis]
30 Companioni O, Bonet C, Muñoz X, Weiderpass E, Panico S, Tumino R, Palli D, Agnoli C, Vineis P, Boutron-Ruault MC, Racine A, Clavel-Chapelon F, Travis RC, Khaw KT, Riboli E, Murphy N, Vergnaud AC, Trichopoulou A, Benetou V, Trichopoulos D, Lund E, Johansen D, Lindkvist B, Johansson M, Sund M, Ardanaz E, Sánchez-Cantalejo E, Huerta JM, Dorronsoro M, Ramón Quirós J, Tjonneland A, Mortensen LM, Overvad K, Chang-Claude J, Rizzato C, Boeing H, Bueno-de-Mesquita HB, Siersema P, Peeters PH, Numans ME, Carneiro F, Licaj I, Freisling H, Sala N, González CA. Polymorphisms of Helicobacter pylori signaling pathway genes and gastric cancer risk in the European Prospective Investigation into Cancer-Eurgast cohort. Int J Cancer 2014;134:92-101. [PMID: 23824692 DOI: 10.1002/ijc.28357] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
31 Kiyono K, Suzuki HI, Morishita Y, Komuro A, Iwata C, Yashiro M, Hirakawa K, Kano MR, Miyazono K. c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-β signaling in diffuse-type gastric carcinoma. Cancer Science 2009;100:1809-16. [DOI: 10.1111/j.1349-7006.2009.01248.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
32 Gomceli I, Demiriz B, Tez M. Gastric carcinogenesis. World J Gastroenterol 2012; 18(37): 5164-5170 [PMID: 23066309 DOI: 10.3748/wjg.v18.i37.5164] [Cited by in F6Publishing: 28] [Reference Citation Analysis]
33 Bou Kheir T, Futoma-Kazmierczak E, Jacobsen A, Krogh A, Bardram L, Hother C, Grønbæk K, Federspiel B, Lund AH, Friis-Hansen L. miR-449 inhibits cell proliferation and is down-regulated in gastric cancer. Mol Cancer 2011;10:29. [PMID: 21418558 DOI: 10.1186/1476-4598-10-29] [Cited by in Crossref: 145] [Cited by in F6Publishing: 158] [Article Influence: 13.2] [Reference Citation Analysis]
34 Singh M, Kumar V, Sehrawat N, Yadav M, Chaudhary M, Upadhyay SK, Kumar S, Sharma V, Kumar S, Dilbaghi N, Sharma AK. Current paradigms in epigenetic anticancer therapeutics and future challenges. Semin Cancer Biol 2021:S1044-579X(21)00063-8. [PMID: 33766649 DOI: 10.1016/j.semcancer.2021.03.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
35 Panani AD. Cytogenetic and molecular aspects of gastric cancer: clinical implications. Cancer Lett. 2008;266:99-115. [PMID: 18381231 DOI: 10.1016/j.canlet.2008.02.053] [Cited by in Crossref: 83] [Cited by in F6Publishing: 78] [Article Influence: 5.9] [Reference Citation Analysis]
36 Kitadai Y. Angiogenesis and lymphangiogenesis of gastric cancer. J Oncol. 2010;2010:468725. [PMID: 20369064 DOI: 10.1155/2010/468725] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
37 Kang W, Tong JH, Chan AW, Lung RW, Chau SL, Wong QW, Wong N, Yu J, Cheng AS, To KF. Stathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer. PLoS One. 2012;7:e33919. [PMID: 22470493 DOI: 10.1371/journal.pone.0033919] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 6.3] [Reference Citation Analysis]
38 Lv W, Chen L. Current status and recent developments in molecular targeted therapy against gastric cancer. Shijie Huaren Xiaohua Zazhi 2007; 15(25): 2672-2678 [DOI: 10.11569/wcjd.v15.i25.2672] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
39 Lee SE, Hong M, Cho J, Lee J, Kim KM. IKKε and TBK1 expression in gastric cancer. Oncotarget 2017;8:16233-42. [PMID: 27145266 DOI: 10.18632/oncotarget.9069] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
40 Sawa T, Mounawar M, Tatemichi M, Gilibert I, Katoh T, Ohshima H. Increased risk of gastric cancer in Japanese subjects is associated with microsatellite polymorphisms in the heme oxygenase-1 and the inducible nitric oxide synthase gene promoters. Cancer Lett. 2008;269:78-84. [PMID: 18502573 DOI: 10.1016/j.canlet.2008.04.015] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
41 Florou D, Papadopoulos IN, Fragoulis EG, Scorilas A. l-Dopa decarboxylase (DDC) constitutes an emerging biomarker in predicting patients’ survival with stomach adenocarcinomas. J Cancer Res Clin Oncol 2013;139:297-306. [DOI: 10.1007/s00432-012-1326-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
42 Guo J, Yu W, Su H, Pang X. Genomic landscape of gastric cancer: molecular classification and potential targets. Sci China Life Sci. 2017;60:126-137. [PMID: 27460193 DOI: 10.1007/s11427-016-0034-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
43 Kit OI, Vodolazhsky DI, Kutilin DS, Gudueva EN. Changes in the number of copies of genetic loci in gastric cancer. Mol Biol 2015;49:589-97. [DOI: 10.1134/s0026893315040093] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
44 Wessler S, Backert S. Molecular mechanisms of epithelial-barrier disruption by Helicobacter pylori. Trends Microbiol. 2008;16:397-405. [PMID: 18619844 DOI: 10.1016/j.tim.2008.05.005] [Cited by in Crossref: 78] [Cited by in F6Publishing: 83] [Article Influence: 5.6] [Reference Citation Analysis]
45 Poltronieri-oliveira AB, Madeira FF, Nunes DBSM, Rodrigues GH, Lopes BC, Manoel-caetano FS, Biselli JM, Silva AE. Polymorphisms of miR-196a2 (rs11614913) and miR-605 (rs2043556) confer susceptibility to gastric cancer. Gene Reports 2017;7:154-63. [DOI: 10.1016/j.genrep.2017.04.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
46 Tang E, Wang Y, Liu T, Yan B. Gastrin promotes angiogenesis by activating HIF-1α/β-catenin/VEGF signaling in gastric cancer. Gene 2019;704:42-8. [PMID: 30980943 DOI: 10.1016/j.gene.2019.04.029] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
47 Pham TM, Fujino Y, Kikuchi S, Tamakoshi A, Yatsuya H, Kubo T, Matsuda S, Yoshimura T; JACC Study Group. A nested case-control study of stomach cancer incidence and serum superoxide dismutase activity in the Japan Collaborative Cohort study in Japan. Cancer Detect Prev 2007;31:431-5. [PMID: 18061374 DOI: 10.1016/j.cdp.2007.10.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Oh S, Kim N, Kwon JW, Shin CM, Choi YJ, Lee DH, Jung HC. Effect of Helicobacter pylori Eradication and ABO Genotype on Gastric Cancer Development. Helicobacter 2016;21:596-605. [PMID: 27191536 DOI: 10.1111/hel.12317] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
49 Radović S, Dorić M, Hukić A, Babić M, Kuskunović S, Spahović N. Immunohistochemical expression and significance of NM23 suppressor protein in primary gastric adenocarcinoma. Bosn J Basic Med Sci 2013;13:72-7. [PMID: 23725501 DOI: 10.17305/bjbms.2013.2368] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
50 Li PF, Chen SC, Xia T, Jiang XM, Shao YF, Xiao BX, Guo JM. Non-coding RNAs and gastric cancer. World J Gastroenterol 2014; 20(18): 5411-5419 [PMID: 24833871 DOI: 10.3748/wjg.v20.i18.5411] [Cited by in CrossRef: 78] [Cited by in F6Publishing: 79] [Article Influence: 9.8] [Reference Citation Analysis]
51 Zhou Y, Lan J, Wang W, Shi Q, Lan Y, Cheng Z, Guan H. ZNRF3 acts as a tumour suppressor by the Wnt signalling pathway in human gastric adenocarcinoma. J Mol Histol. 2013;44:555-563. [PMID: 23504200 DOI: 10.1007/s10735-013-9504-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
52 Dicksved J, Lindberg M, Rosenquist M, Enroth H, Jansson JK, Engstrand L. Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. J Med Microbiol. 2009;58:509-516. [PMID: 19273648 DOI: 10.1099/jmm.0.007302-0] [Cited by in Crossref: 176] [Cited by in F6Publishing: 162] [Article Influence: 13.5] [Reference Citation Analysis]
53 Palacio-Rúa KA, Isaza-Jiménez LF, Ahumada-Rodríguez E, Muñetón-Peña CM. Genetic analysis in APC, KRAS, and TP53 in patients with stomach and colon cancer. Rev Gastroenterol Mex 2014;79:79-89. [PMID: 24861525 DOI: 10.1016/j.rgmx.2014.05.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
54 Kim BJ, Kim YJ, Sohn SH, Kim B, Sul HJ, Kim HS, Zang DY. Tivantinib inhibits the VEGF signaling pathway and induces apoptosis in gastric cancer cells with c-MET or VEGFA amplification. Invest New Drugs 2020;38:1633-40. [PMID: 32361789 DOI: 10.1007/s10637-020-00940-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
55 Xie Y, Liu L. Analysis of correlation between HP infection and activation of PI3K/Akt pathway in mucosal tissues of gastric cancer and precancerous lesions. Oncol Lett 2018;16:5615-20. [PMID: 30344716 DOI: 10.3892/ol.2018.9329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
56 Wu Y, Jiang Z. Relationship between Helicobacter pylori and DNA mismatch repair system. Shijie Huaren Xiaohua Zazhi 2007; 15(1): 51-55 [DOI: 10.11569/wcjd.v15.i1.51] [Reference Citation Analysis]
57 Liu N, Wu Y, Cheng W, Wu Y, Wang L, Zhuang L. Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer. BMC Cancer 2021;21:460. [PMID: 33902514 DOI: 10.1186/s12885-021-08210-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
58 Li PF, Chen SC, Xia T, Jiang XM, Shao YF, Xiao BX, Guo JM. Non-coding RNAs and gastric cancer. World J Gastroenterol. 2014;20:5411-5419. [PMID: 24833871 DOI: 10.3748/wjg.v20.i18. 5411] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
59 Lochhead P, El-Omar EM. Helicobacter pylori infection and gastric cancer. Best Pract Res Clin Gastroenterol. 2007;21:281-297. [PMID: 17382277 DOI: 10.1016/j.bpg.2007.02.002] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 4.4] [Reference Citation Analysis]
60 Mattioli E, Vogiatzi P, Sun A, Abbadessa G, Angeloni G, D’Ugo D, Trani D, Gaughan JP, Vecchio FM, Cevenini G. Immunohistochemical analysis of pRb2/p130, VEGF, EZH2, p53, p16(INK4A), p27(KIP1), p21(WAF1), Ki-67 expression patterns in gastric cancer. J Cell Physiol. 2007;210:183-191. [PMID: 16998811 DOI: 10.1002/jcp.20833] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 3.4] [Reference Citation Analysis]
61 Hosoda F, Arai Y, Okada N, Shimizu H, Miyamoto M, Kitagawa N, Katai H, Taniguchi H, Yanagihara K, Imoto I, Inazawa J, Ohki M, Shibata T. Integrated genomic and functional analyses reveal glyoxalase I as a novel metabolic oncogene in human gastric cancer. Oncogene 2015;34:1196-206. [PMID: 24662817 DOI: 10.1038/onc.2014.57] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
62 Sykes PD, Neoptolemos JP, Costello E, Halloran CM. Nanotechnology advances in upper gastrointestinal, liver and pancreatic cancer. Expert Review of Gastroenterology & Hepatology 2014;6:343-56. [DOI: 10.1586/egh.12.13] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
63 Ayala G, Flores-Luna L, Hernández-Amaro D, Mendoza-Hernández G, Chihu-Amparán L, Bernal-Sahagún F, Camorlinga M, Lazcano-Ponce E, Torres J. Association of circulating VacA-neutralizing antibodies with gastric cancer and duodenal ulcer. Cancer Causes Control. 2011;22:1425-1434. [PMID: 21779758 DOI: 10.1007/s10552-011-9817-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
64 Ando S, Abe R, Sasaki M, Murata J, Inokuma D, Shimizu H. Bone marrow-derived cells are not the origin of the cancer stem cells in ultraviolet-induced skin cancer. Am J Pathol 2009;174:595-601. [PMID: 19131588 DOI: 10.2353/ajpath.2009.080362] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
65 Sugai T, Habano W, Endoh M, Konishi Y, Akasaka R, Toyota M, Yamano H, Koeda K, Wakabayashi G, Suzuki K. Molecular analysis of gastric differentiated-type intramucosal and submucosal cancers. Int J Cancer. 2010;127:2500-2509. [PMID: 20178104 DOI: 10.1002/ijc.25271] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
66 Zhang X, Zheng Z, Shin YK, Kim KY, Rha SY, Noh SH, Chung HC, Jeung HC. Angiogenic factor thymidine phosphorylase associates with angiogenesis and lymphangiogenesis in the intestinal-type gastric cancer. Pathology. 2014;46:316-324. [PMID: 24798152 DOI: 10.1097/pat.0000000000000094] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
67 Shi H, Wang X, Wang J, Pan J, Liu J, Ye B. Association between CHFR gene hypermethylation and gastric cancer risk: a meta-analysis. Onco Targets Ther 2016;9:7409-14. [PMID: 27994471 DOI: 10.2147/OTT.S118070] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
68 Vale FF, Vítor JM. Genomic methylation: a tool for typing Helicobacter pylori isolates. Appl Environ Microbiol 2007;73:4243-9. [PMID: 17483255 DOI: 10.1128/AEM.00199-07] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
69 Gonçalves AR, Carneiro AJ, Martins I, de Faria PA, Ferreira MA, de Mello EL, Fogaça HS, Elia CC, de Souza HS. Prognostic significance of p53 protein expression in early gastric cancer. Pathol Oncol Res 2011;17:349-55. [PMID: 21116760 DOI: 10.1007/s12253-010-9333-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
70 André AR, Ferreira MV, Mota RM, Ferrasi AC, Pardini MI, Rabenhorst SH. Gastric adenocarcinoma and Helicobacter pylori: correlation with p53 mutation and p27 immunoexpression. Cancer Epidemiol 2010;34:618-25. [PMID: 20541486 DOI: 10.1016/j.canep.2010.05.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
71 Santos JC, Ribeiro ML. Epigenetic regulation of DNA repair machinery in Helicobacter pylori-induced gastric carcinogenesis. World J Gastroenterol 2015; 21(30): 9021-9037 [PMID: 26290630 DOI: 10.3748/wjg.v21.i30.9021] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
72 Denson LA. Adding fuel to the fire: STAT3 priming of gastric tumorigenesis. Gastroenterology. 2006;131:1342-1344. [PMID: 17030202 DOI: 10.1053/j.gastro.2006.08.049] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
73 Al-Moundhri MS, Al-Kindi M, Al-Nabhani M, Al-Bahrani B, Burney IA, Al-Madhani A, Ganguly SS, Tanira M. NAT2 polymorphism in Omani gastric cancer patients-risk predisposition and clinicopathological associations. World J Gastroenterol 2007; 13(19): 2697-2702 [PMID: 17569138 DOI: 10.3748/wjg.v13.i19.2697] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
74 Sung JJY, Coker OO, Chu E, Szeto CH, Luk STY, Lau HCH, Yu J. Gastric microbes associated with gastric inflammation, atrophy and intestinal metaplasia 1 year after Helicobacter pylori eradication. Gut. 2020;69:1572-1580. [PMID: 31974133 DOI: 10.1136/gutjnl-2019-319826] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
75 Cui X, Zhang H, Cao A, Cao L, Hu X. Cytokine TNF-α promotes invasion and metastasis of gastric cancer by down-regulating Pentraxin3. J Cancer 2020;11:1800-7. [PMID: 32194791 DOI: 10.7150/jca.39562] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
76 Lima VP, Silva-Fernandes IJ, Alves MK, Rabenhorst SH. Prevalence of Helicobacter pylori genotypes (vacA, cagA, cagE and virB11) in gastric cancer in Brazilian’s patients: an association with histopathological parameters. Cancer Epidemiol. 2011;35:e32-e37. [PMID: 21470935 DOI: 10.1016/j.canep.2011.02.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
77 Cadamuro ACT, Rossi AFT, Maniezzo NM, Silva AE. Helicobacter pylori infection: Host immune response, implications on gene expression and microRNAs. World J Gastroenterol 2014; 20(6): 1424-1437 [PMID: 24587619 DOI: 10.3748/wjg.v20.i6.1424] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 46] [Article Influence: 6.6] [Reference Citation Analysis]
78 Hold GL, Hansen R. Impact of the Gastrointestinal Microbiome in Health and Disease: Co-evolution with the Host Immune System. Curr Top Microbiol Immunol 2019;421:303-18. [PMID: 31123894 DOI: 10.1007/978-3-030-15138-6_12] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
79 Jeong SH, Lee YJ, Cho BI, Ha WS, Choi SK, Jung EJ, Ju YT, Jeong CY, Ko GH, Yoo J, Hong SC. OCT-1 overexpression is associated with poor prognosis in patients with well-differentiated gastric cancer. Tumour Biol 2014;35:5501-9. [PMID: 24566898 DOI: 10.1007/s13277-014-1724-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
80 Calcagno DQ, Leal MF, Assumpção PP, Smith MAC, Burbano RR. MYC and gastric adenocarcinoma carcinogenesis. World J Gastroenterol 2008; 14(39): 5962-5968 [PMID: 18932273 DOI: 10.3748/wjg.14.5962] [Cited by in CrossRef: 71] [Cited by in F6Publishing: 73] [Article Influence: 5.1] [Reference Citation Analysis]
81 Zhang B, Yang Y, Shi X, Liao W, Chen M, Cheng AS, Yan H, Fang C, Zhang S, Xu G. Proton pump inhibitor pantoprazole abrogates adriamycin-resistant gastric cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin signaling and epithelial-mesenchymal transition. Cancer Lett. 2015;356:704-712. [PMID: 25449432 DOI: 10.1016/j.canlet.2014.10.016] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 6.1] [Reference Citation Analysis]
82 Bhaskar Rao D, Devanandan HJ, Ganesan K. Identification of kinases and kinase inhibitors for the differential targeting of Wnt/β-catenin signaling in gastric cancer subtypes. Drug Dev Res 2021. [PMID: 34002415 DOI: 10.1002/ddr.21833] [Reference Citation Analysis]
83 Zhou LP, Luan H, Dong XH, Jin GJ, Man DL, Shang H. Vascular endothelial growth factor +936C/T polymorphism and gastric cancer risk: A meta-analysis. Exp Ther Med 2011;2:931-6. [PMID: 22977600 DOI: 10.3892/etm.2011.278] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
84 Fumagalli M, Sangiovanni E, Vrhovsek U, Piazza S, Colombo E, Gasperotti M, Mattivi F, De Fabiani E, Dell'Agli M. Strawberry tannins inhibit IL-8 secretion in a cell model of gastric inflammation. Pharmacol Res 2016;111:703-12. [PMID: 27473819 DOI: 10.1016/j.phrs.2016.07.028] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
85 Companioni O, Bonet C, García N, Ramírez-lázaro MJ, Lario S, Mendoza J, Adrados MM, Poves E, Espinosa L, Pozo-kreilinger JJ, Ortega L, Bujanda L, Cosme A, Ferrández A, Muñoz G, Cuatrecasas M, Elizalde I, Andreu V, Paules MJ, Madrigal B, Barrio J, Berdasco M, Calvet X, Sanz-anquela JM, Gisbert JP, González CA, Sala N; on behalf of the Study Group. Genetic variation analysis in a follow-up study of gastric cancer precursor lesions confirms the association of MUC2 variants with the evolution of the lesions and identifies a significant association with NFKB1 and CD14: Genetic variation and gastric cancer precursor lesions. Int J Cancer 2018;143:2777-86. [DOI: 10.1002/ijc.31839] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
86 Tanaka M, Kitadai Y, Kodama M, Shinagawa K, Sumida T, Tanaka S, Oue N, Yasui W, Chayama K. Potential role for vascular endothelial growth factor-D as an autocrine factor for human gastric carcinoma cells. Cancer Sci. 2010;101:2121-2127. [PMID: 20626397 DOI: 10.1111/j.1349-7006.2010.01649.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
87 Cheng XJ, Lin JC, Ding YF, Zhu L, Ye J, Tu SP. Survivin inhibitor YM155 suppresses gastric cancer xenograft growth in mice without affecting normal tissues. Oncotarget 2016;7:7096-109. [PMID: 26771139 DOI: 10.18632/oncotarget.6898] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
88 Kuai WX, Wang Q, Yang XZ, Zhao Y, Yu R, Tang XJ. Interleukin-8 associates with adhesion, migration, invasion and chemosensitivity of human gastric cancer cells. World J Gastroenterol. 2012;18:979-985. [PMID: 22408359 DOI: 10.3748/wjg.v18.i9.979.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
89 He XP, Shao Y, Li XL, Xu W, Chen GS, Sun HH, Xu HC, Xu X, Tang D, Zheng XF, Xue YP, Huang GC, Sun WH. Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth. FEBS J 2012;279:4201-12. [PMID: 23013439 DOI: 10.1111/febs.12013] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 7.2] [Reference Citation Analysis]
90 Verzi MP, Shivdasani RA. Wnt signaling in gut organogenesis. Organogenesis 2008;4:87-91. [PMID: 19279719 DOI: 10.4161/org.4.2.5854] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
91 Radulescu S, Ridgway RA, Cordero J, Athineos D, Salgueiro P, Poulsom R, Neumann J, Jung A, Patel S, Woodgett J. Acute WNT signalling activation perturbs differentiation within the adult stomach and rapidly leads to tumour formation. Oncogene. 2013;32:2048-2057. [PMID: 22665058 DOI: 10.1038/onc.2012.224] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
92 Shrestha S, Yang CD, Hong HC, Chou CH, Tai CS, Chiew MY, Chen WL, Weng SL, Chen CC, Chang YA, Lee ML, Huang WY, Hsu SD, Chen YC, Huang HD. Integrated MicroRNA-mRNA Analysis Reveals miR-204 Inhibits Cell Proliferation in Gastric Cancer by Targeting CKS1B, CXCL1 and GPRC5A. Int J Mol Sci 2017;19:E87. [PMID: 29283424 DOI: 10.3390/ijms19010087] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
93 Levidou G, Korkolopoulou P, Nikiteas N, Tzanakis N, Thymara I, Saetta AA, Tsigris C, Rallis G, Vlasis K, Patsouris E. Expression of Nuclear Factor κB in Human Gastric Carcinoma: Relationship with IκBa and Prognostic Significance. Virchows Archiv. 2007;450:519-527. [PMID: 17429689 DOI: 10.1007/s00428-007-0396-5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
94 Hold GL, Mukhopadhya I, Monie TP. Innate immune sensors and gastrointestinal bacterial infections. Clin Dev Immunol. 2011;2011:579650. [PMID: 21647408 DOI: 10.1155/2011/579650] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
95 Wang X, Wang X, Liu Y, Dong Y, Wang Y, Kassab MA, Fan W, Yu X, Wu C. LGR5 regulates gastric adenocarcinoma cell proliferation and invasion via activating Wnt signaling pathway. Oncogenesis 2018;7:57. [PMID: 30089773 DOI: 10.1038/s41389-018-0071-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
96 Fu DG. Epigenetic alterations in gastric cancer (Review). Mol Med Rep 2015;12:3223-30. [PMID: 25997695 DOI: 10.3892/mmr.2015.3816] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 6.4] [Reference Citation Analysis]
97 Li LP, Wu WJ, Sun DY, Xie ZY, Ma YC, Zhao YG. miR-449a and CDK6 in gastric carcinoma. Oncol Lett 2014;8:1533-8. [PMID: 25202363 DOI: 10.3892/ol.2014.2370] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
98 Cárdenas DM, Sánchez AC, Rosas DA, Rivero E, Paparoni MD, Cruz MA, Suárez YP, Galvis NF. Preliminary analysis of single-nucleotide polymorphisms in IL-10, IL-4, and IL-4Rα genes and profile of circulating cytokines in patients with gastric Cancer. BMC Gastroenterol 2018;18:184. [PMID: 30526523 DOI: 10.1186/s12876-018-0913-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
99 Mukherjee K, Peng D, Brifkani Z, Belkhiri A, Pera M, Koyama T, Koehler EA, Revetta FL, Washington MK, El-Rifai W. Dopamine and cAMP regulated phosphoprotein MW 32 kDa is overexpressed in early stages of gastric tumorigenesis. Surgery 2010;148:354-63. [PMID: 20580047 DOI: 10.1016/j.surg.2010.05.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
100 Zhao Z, Wang L, Song W, Cui H, Chen G, Qiao F, Hu J, Zhou R, Fan H. Reduced miR-29a-3p expression is linked to the cell proliferation and cell migration in gastric cancer. World J Surg Oncol 2015;13:101. [PMID: 25889078 DOI: 10.1186/s12957-015-0513-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 4.3] [Reference Citation Analysis]
101 Sheibani S, Mahmoudian RA, Abbaszadegan MR, Chamani J, Memar B, Gholamin M. Expression analysis of matrix metalloproteinase-13 in human gastric cancer in the presence of Helicobacter Pylori infection. Cancer Biomark 2017;18:349-56. [PMID: 28128735 DOI: 10.3233/CBM-160127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
102 Wang F, Luo LD, Pan JH, Huang LH, Lv HW, Guo Q, Xu CX, Shen SR. Comparative genomic study of gastric epithelial cells co-cultured with Helicobacter pyloriWorld J Gastroenterol 2012; 18(48): 7212-7224 [PMID: 23326126 DOI: 10.3748/wjg.v18.i48.7212] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
103 Kuai WX, Wang Q, Yang XZ, Zhao Y, Yu R, Tang XJ. Interleukin-8 associates with adhesion, migration, invasion and chemosensitivity of human gastric cancer cells. World J Gastroenterol 2012; 18(9): 979-985 [PMID: 22408359 DOI: 10.3748/wjg.v18.i9.979] [Cited by in CrossRef: 71] [Cited by in F6Publishing: 70] [Article Influence: 7.1] [Reference Citation Analysis]
104 Yuan KT, Li BX, Yuan YJ, Tan M, Tan JF, Dai WG, Feng WD, Zuo JD. Deregulation of MicroRNA-375 Inhibits Proliferation and Migration in Gastric Cancer in Association With Autophagy-Mediated AKT/mTOR Signaling Pathways. Technol Cancer Res Treat. 2018;17:1533033818806499. [PMID: 30355273 DOI: 10.1177/1533033818806499] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
105 Alvarez MC, Santos JC, Maniezzo N, Ladeira MS, da Silva AL, Scaletsky IC, Pedrazzoli Jr J, Ribeiro ML. MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults. World J Gastroenterol 2013; 19(20): 3043-3051 [PMID: 23716983 DOI: 10.3748/wjg.v19.i20.3043] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
106 Calcagno DQ, Freitas VM, Leal MF, de Souza CR, Demachki S, Montenegro R, Assumpção PP, Khayat AS, Smith Mde A, dos Santos AK, Burbano RR. MYC, FBXW7 and TP53 copy number variation and expression in gastric cancer. BMC Gastroenterol 2013;13:141. [PMID: 24053468 DOI: 10.1186/1471-230X-13-141] [Cited by in Crossref: 62] [Cited by in F6Publishing: 48] [Article Influence: 6.9] [Reference Citation Analysis]
107 Johnson SM, Evers BM. Translational research in gastric malignancy. Surg Oncol Clin N Am 2008;17:323-40, viii. [PMID: 18375355 DOI: 10.1016/j.soc.2008.01.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
108 Wu X, Yang T, Liu X, Guo JN, Xie T, Ding Y, Lin M, Yang H. IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer. Tumour Biol 2016;37:5493-501. [PMID: 26566627 DOI: 10.1007/s13277-015-4372-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
109 Palacio-rúa K, Isaza-jiménez L, Ahumada-rodríguez E, Ceballos-garcía H, Muñetón-peña C. Genetic analysis in APC, KRAS, and TP53 in patients with stomach and colon cancer. Revista de Gastroenterología de México (English Edition) 2014;79:79-89. [DOI: 10.1016/j.rgmxen.2014.06.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
110 Mbulaiteye SM. Helicobacter Pylori associated global gastric cancer burden. Front Biosci 2009;Volume:1490. [DOI: 10.2741/3320] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 4.1] [Reference Citation Analysis]
111 Kwon CH, Moon HJ, Park HJ, Choi JH, Park do Y. S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-κB activation in gastric cancer cells. Mol Cells. 2013;35:226-234. [PMID: 23456298 DOI: 10.1007/s10059-013-2269-x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 8.0] [Reference Citation Analysis]
112 Gong AM, Li XY, Xie YQ, Jia ZD, Li YX, Zou YY, Xu CQ, Wang ZY. Association between CD14 SNP -159 C/T and gastric cancer: an independent case-control study and an updated meta-analysis. Onco Targets Ther 2016;9:4337-42. [PMID: 27486336 DOI: 10.2147/OTT.S95807] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
113 Kitadai Y. Cancer-stromal cell interaction and tumor angiogenesis in gastric cancer. Cancer Microenviron. 2010;3:109-116. [PMID: 20020278 DOI: 10.1007/s12307-009-0032-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 3.3] [Reference Citation Analysis]
114 Cai H, Chen J, He B, Li Q, Li Y, Gao Y. A FOXM1 related long non-coding RNA contributes to gastric cancer cell migration. Mol Cell Biochem. 2015;406:31-41. [PMID: 25907137 DOI: 10.1007/s11010-015-2421-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
115 Regalo G, Leutz A. Hacking cell differentiation: transcriptional rerouting in reprogramming, lineage infidelity and metaplasia. EMBO Mol Med 2013;5:1154-64. [PMID: 23828660 DOI: 10.1002/emmm.201302834] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
116 Stenholm L, Stoehlmacher-Williams J, Al-Batran SE, Heussen N, Akin S, Pauligk C, Lehmann S, Senff T, Hofheinz RD, Ehninger G, Kramer M, Goekkurt E. Prognostic role of microRNA polymorphisms in advanced gastric cancer: A translational study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). Ann Oncol. 2013;24:2581-2588. [PMID: 23975664 DOI: 10.1093/annonc/mdt330] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
117 Tomoda A, Miyazawa K, Tabuchi T. Prevention of carcinogenesis and development of gastric and colon cancers by 2-aminophenoxazine-3-one (Phx-3): direct and indirect anti-cancer activity of Phx-3. Int J Mol Sci 2013;14:17573-83. [PMID: 23989604 DOI: 10.3390/ijms140917573] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
118 Lin T, Ding YQ, Li JM. Overexpression of Nanog protein is associated with poor prognosis in gastric adenocarcinoma. Med Oncol. 2012;29:878-885. [PMID: 21336986 DOI: 10.1007/s12032-011-9860-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 55] [Article Influence: 4.4] [Reference Citation Analysis]
119 Zhu BH, Chen HY, Zhan WH, Wang CY, Cai SR, Wang Z, Zhang CH, He YL. (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer. World J Gastroenterol 2011; 17(18): 2315-2325 [PMID: 21633597 DOI: 10.3748/wjg.v17.i18.2315] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
120 Huang H, Yang Y, Zhang W, Liu X, Yang G. TTK regulates proliferation and apoptosis of gastric cancer cells through the Akt-mTOR pathway. FEBS Open Bio 2020;10:1542-9. [PMID: 32530571 DOI: 10.1002/2211-5463.12909] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
121 Al-Moundhri MS, Alkindy M, Al-Nabhani M, Al-Bahrani B, Burney IA, Al-Habsi H, Ganguly SS, Tanira M. Combined polymorphism analysis of glutathione S-transferase M1/G1 and interleukin-1B (IL-1B)/interleukin 1-receptor antagonist (IL-1RN) and gastric cancer risk in an Omani Arab Population. J Clin Gastroenterol. 2009;43:152-156. [PMID: 18779738 DOI: 10.1097/mcg.0b013e31815853fa] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
122 Freire P, Figueiredo P, Cardoso R, Donato MM, Sá A, Portela F, Romãozinho JM, Sofia C. Card15 mutations and gastric cancer in a Portuguese population. Scand J Gastroenterol 2013;48:1188-97. [PMID: 24047397 DOI: 10.3109/00365521.2013.832370] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
123 Lee YJ, Han ME, Baek SJ, Kim SY, Oh SO. MED30 Regulates the Proliferation and Motility of Gastric Cancer Cells. PLoS One 2015;10:e0130826. [PMID: 26110885 DOI: 10.1371/journal.pone.0130826] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
124 Lertpiriyapong K, Whary MT, Muthupalani S, Lofgren JL, Gamazon ER, Feng Y, Ge Z, Wang TC, Fox JG. Gastric colonisation with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis. Gut. 2014;63:54-63. [PMID: 23812323 DOI: 10.1136/gutjnl-2013-305178] [Cited by in Crossref: 124] [Cited by in F6Publishing: 116] [Article Influence: 13.8] [Reference Citation Analysis]
125 Ren F, Zhao Q, Liu B, Sun X, Tang Y, Huang H, Mei L, Yu Y, Mo H, Dong H, Zheng P, Mi Y. Transcriptome analysis reveals GPNMB as a potential therapeutic target for gastric cancer. J Cell Physiol 2020;235:2738-52. [PMID: 31498430 DOI: 10.1002/jcp.29177] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
126 Kitadai Y, Kodama M, Shinagawa K. Stroma-directed molecular targeted therapy in gastric cancer. Cancers (Basel) 2011;3:4245-57. [PMID: 24213136 DOI: 10.3390/cancers3044245] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
127 Uehara T, Kikuchi H, Miyazaki S, Iino I, Setoguchi T, Hiramatsu Y, Ohta M, Kamiya K, Morita Y, Tanaka H, Baba S, Hayasaka T, Setou M, Konno H. Overexpression of Lysophosphatidylcholine Acyltransferase 1 and Concomitant Lipid Alterations in Gastric Cancer. Ann Surg Oncol. 2016;23 Suppl 2:S206-S213. [PMID: 25752890 DOI: 10.1245/s10434-015-4459-6] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 7.6] [Reference Citation Analysis]
128 Nakonieczna S, Grabarska A, Kukula-Koch W. The Potential Anticancer Activity of Phytoconstituents against Gastric Cancer-A Review on In Vitro, In Vivo, and Clinical Studies. Int J Mol Sci 2020;21:E8307. [PMID: 33167519 DOI: 10.3390/ijms21218307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
129 Bellini MF, Cadamuro AC, Succi M, Proença MA, Silva AE. Alterations of the TP53 gene in gastric and esophageal carcinogenesis. J Biomed Biotechnol. 2012;2012:891961. [PMID: 22919278 DOI: 10.1155/2012/891961] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
130 Kim N. Chemoprevention of gastric cancer by Helicobacter pylori eradication and its underlying mechanism. J Gastroenterol Hepatol 2019;34:1287-95. [PMID: 30828872 DOI: 10.1111/jgh.14646] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
131 Study Group of Millennium Genome Project for Cancer; Sakamoto H, Yoshimura K, Saeki N, Katai H, Shimoda T, Matsuno Y, Saito D, Sugimura H, Tanioka F, Kato S, Matsukura N, Matsuda N, Nakamura T, Hyodo I, Nishina T, Yasui W, Hirose H, Hayashi M, Toshiro E, Ohnami S, Sekine A, Sato Y, Totsuka H, Ando M, Takemura R, Takahashi Y, Ohdaira M, Aoki K, Honmyo I, Chiku S, Aoyagi K, Sasaki H, Yanagihara K, Yoon KA, Kook MC, Lee YS, Park SR, Kim CG, Choi IJ, Yoshida T, Nakamura Y, Hirohashi S. Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet. 2008;40:730-740. [PMID: 18488030 DOI: 10.1038/ng.152] [Cited by in Crossref: 283] [Cited by in F6Publishing: 271] [Article Influence: 20.2] [Reference Citation Analysis]
132 Osaki M, Inoue T, Yamaguchi S, Inaba A, Tokuyasu N, Jeang KT, Oshimura M, Ito H. MAD1 (mitotic arrest deficiency 1) is a candidate for a tumor suppressor gene in human stomach. Virchows Arch. 2007;451:771-779. [PMID: 17674037 DOI: 10.1007/s00428-007-0470-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
133 Hsu KW, Hsieh RH, Huang KH, Fen-Yau Li A, Chi CW, Wang TY, Tseng MJ, Wu KJ, Yeh TS. Activation of the Notch1/STAT3/Twist signaling axis promotes gastric cancer progression. Carcinogenesis. 2012;33:1459-1467. [PMID: 22581828 DOI: 10.1093/carcin/bgs165] [Cited by in Crossref: 82] [Cited by in F6Publishing: 81] [Article Influence: 8.2] [Reference Citation Analysis]
134 Carcas LP. Gastric cancer review. J Carcinog. 2014;13:14. [PMID: 25589897 DOI: 10.4103/1477-3163.146506] [Cited by in Crossref: 126] [Cited by in F6Publishing: 126] [Article Influence: 15.8] [Reference Citation Analysis]
135 Satomi Takeno S, Leal MF, Frias Lisboa LC, Nunes Lipay MV, Khayat AS, Assumpção PP, Burbano RR, de Arruda Cardoso Smith M. Genomic alterations in diffuse-type gastric cancer as shown by high-resolution comparative genomic hybridization. Cancer Genetics and Cytogenetics 2009;190:1-7. [DOI: 10.1016/j.cancergencyto.2008.09.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
136 Hsu KW, Hsieh RH, Wu CW, Chi CW, Lee YH, Kuo ML, Wu KJ, Yeh TS. MBP-1 suppresses growth and metastasis of gastric cancer cells through COX-2. Mol Biol Cell 2009;20:5127-37. [PMID: 19846662 DOI: 10.1091/mbc.e09-05-0386] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
137 Ge L, Wang Y, Duan QH, Liu SS, Liu GJ. MicroRNA-760 acts as a tumor suppressor in gastric cancer development via inhibiting G-protein-coupled receptor kinase interacting protein-1 transcription. World J Gastroenterol 2019; 25(45): 6619-6633 [PMID: 31832002 DOI: 10.3748/wjg.v25.i45.6619] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
138 Vahidi S, Norollahi SE, Agah S, Samadani AA. DNA Methylation Profiling of hTERT Gene Alongside with the Telomere Performance in Gastric Adenocarcinoma. J Gastrointest Cancer 2020;51:788-99. [PMID: 32617831 DOI: 10.1007/s12029-020-00427-7] [Reference Citation Analysis]
139 Xu W, Chen GS, Shao Y, Li XL, Xu HC, Zhang H, Zhu GQ, Zhou YC, He XP, Sun WH. Gastrin acting on the cholecystokinin2 receptor induces cyclooxygenase-2 expression through JAK2/STAT3/PI3K/Akt pathway in human gastric cancer cells. Cancer Lett. 2013;332:11-18. [PMID: 23376640 DOI: 10.1016/j.canlet.2012.12.030] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
140 Wessler S, Gimona M, Rieder G. Regulation of the actin cytoskeleton in Helicobacter pylori-induced migration and invasive growth of gastric epithelial cells. Cell Commun Signal. 2011;9:27. [PMID: 22044652 DOI: 10.1186/1478-811x-9-27] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
141 Holmes K, Egan B, Swan N, O'Morain C. Genetic Mechanisms and Aberrant Gene Expression during the Development of Gastric Intestinal Metaplasia and Adenocarcinoma. Curr Genomics. 2007;8:379-397. [PMID: 19412438 DOI: 10.2174/138920207783406460] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
142 Wu X, Yang T, Liu X, Guo JN, Xie T, Ding Y, Lin M, Yang H. IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer. Tumour Biol. 2016;37:5493-5501. [PMID: 26566627 DOI: 10.1007/s13277-015-4372] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
143 Leal MF, Calcagno DQ, Demachki S, Assumpção PP, Chammas R, Burbano RR, Smith MAC. Clinical implication of 14-3-3 epsilon expression in gastric cancer. World J Gastroenterol 2012; 18(13): 1531-1537 [PMID: 22509086 DOI: 10.3748/wjg.v18.i13.1531] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
144 Eshaghi Malekshah R, Salehi M, Kubicki M, Khaleghian A. Biological studies and computational modeling of two new copper complexes derived from β -diketones and their nano-complexes. Journal of Coordination Chemistry 2019;72:1697-714. [DOI: 10.1080/00958972.2019.1606422] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
145 Chen J, Ying X, Zhang L, Xiang X, Xiong J. Influence of TS and ABCB1 gene polymorphisms on survival outcomes of 5‑FU-based chemotherapy in a Chinese population of advanced gastric cancer patients. Wien Klin Wochenschr 2017;129:420-6. [DOI: 10.1007/s00508-016-1147-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
146 Shaoul R, Eliahu L, Sher I, Hamlet Y, Miselevich I, Goldshmidt O, Ron D. Elevated expression of FGF7 protein is common in human gastric diseases. Biochemical and Biophysical Research Communications 2006;350:825-33. [DOI: 10.1016/j.bbrc.2006.08.198] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]